Location History:
- Chavannes-pres-renens, CH (2014)
- Chavennes-pres-Renens, CH (2014)
Company Filing History:
Years Active: 2014
Title: Maria Jimenez: Innovator in Adipogenesis Modulation
Introduction
Maria Jimenez is a prominent inventor based in Chavannes-pres-Renens, Switzerland. She has made significant contributions to the field of adipogenesis modulation, focusing on innovative methods to treat obesity and related disorders. With a total of three patents to her name, her work is paving the way for new therapeutic approaches.
Latest Patents
Maria's latest patents include the "Use of Vgll3 activity modulator for the modulation of adipogenesis." This invention identifies Vgll3 as a new target involved in adipogenesis modulation. The patent outlines methods to increase Vgll3 activity in adipocytes and preadipocytes. Additionally, it provides pharmaceutical compositions comprising Vgll3 activity-enhancing molecules, which can be useful in modulating adipogenesis and treating obesity-related disorders.
Another significant patent is the "Use of inhibitors of Zdhhc2 activity for modulation of adipogenesis." This invention highlights Zdhhc2 as a new target for adipogenesis modulation. Through a siRNA approach, Maria and her team demonstrated that a decrease in Zdhhc2 activity in adipose tissue leads to reduced adipogenesis. The patent includes modulators of Zdhhc2 activity and screening tests for identifying these modulators, emphasizing their potential use in pharmaceutical compositions to treat obesity and related disorders.
Career Highlights
Maria Jimenez is currently employed at Sanofi, a global healthcare leader. Her work at Sanofi has allowed her to focus on innovative research aimed at addressing critical health issues related to obesity. Her dedication to advancing scientific knowledge in this area has positioned her as a key figure in the field.
Collaborations
Maria collaborates with talented coworkers, including Diana Hall and Carine Poussin. These partnerships enhance her research efforts and contribute to the development of groundbreaking solutions in adipogenesis modulation.
Conclusion
Maria Jimenez is a trailblazer in the field of adipogenesis modulation, with her innovative patents offering promising avenues for treating obesity and related disorders. Her work at Sanofi and collaborations with esteemed colleagues further amplify her impact in the scientific community.